XPONANCE, INC. – Eli Lilly and Company Transaction History
XPONANCE, INC. portfolio value:
$47.31M
portfolio value
XPONANCE, INC. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +7.68% | 10.43K shares | 3.25M | $323.35 | 146.31K |
| Q2 2022 | share | Increase | +0.55% | 748 shares | 5.35M | $324.23 | 135.87K |
| Q1 2022 | share | Increase | +12.95% | 15.48K shares | 5.65M | $286.37 | 135.12K |
| Q4 2021 | share | Decrease | -2.50% | -3.06K shares | 4.69M | $277.25 | 119.63K |
| Q3 2021 | share | Decrease | -8.37% | -11.20K shares | -2.38M | $230.3 | 122.70K |
| Q2 2021 | share | Decrease | -10.38% | -15.51K shares | 2.82M | $228.04 | 133.90K |
| Q1 2021 | share | Decrease | -0.30% | -455 shares | 2.61M | $184.81 | 149.42K |
| Q4 2020 | share | Increase | +0.57% | 851 shares | 3.24M | $166.32 | 149.87K |